https://pittplusme.org/study/2122
NASH Cirrhosis Study
This study is not currently recruiting. Please check back at a later time.
STUDY BASICS
Are you 18-75 and diagnosed with a type of liver disease called compensated NASH cirrhosis without varices? You may be able to participate in a study to help find out if a study drug called Belapectin is safe and works to prevent enlarged veins in the esophagus in NASH Cirrhosis. Participation could last about 39 months if participating in both states of the trial. Compensation is provided.
IRB: SSU00275534
- Galectin Therapeutics Inc. - GT-031 (NASH-RX), A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GRMD- 02) for the Prevention of Esophageal Varices in NASH Cirrhosis (Pro00043696)
AGE:
18-75
DURATION:
About 39 months for both stages of the trial
VISITS:
Study drug infusion every 2 weeks
LOCATION:
UPMC Center for Liver Diseases - Oakland
COMPENSATION:
$60 per completed study visit
SHARE STUDY
